Key result
Clopidogrel is reviewed as a potential first-line alternative to aspirin for secondary prevention following selected minor ischemic strokes.
Why the study?
Does clopidogrel improve secondary prevention compared to aspirin in patients following selected minor ischaemic strokes?
Does clopidogrel improve secondary prevention compared to aspirin in patients following selected minor ischaemic strokes?
Answers are grounded in this paper and cite their sources.
This article discusses whether clopidogrel should replace aspirin as the first-line choice for secondary prevention after minor ischemic strokes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question. Clopidogrel is reviewed as a potential first-line alternative to aspirin for secondary prevention following selected minor ischemic strokes.
Synapse has enriched 10 related papers. Consider them for comparative context: